Brendan Smyth
0000-0003-1838-3348
7 papers found
Refreshing results…
Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection‐extended review
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis
Varying Association of Extended Hours Dialysis with Quality of Life
Missing publications? Search for publications with a matching author name.